ether has been researched along with pyrroloquinoline in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, B; Chen, Y; Dong, H; Gu, Z; Lin, F; Nieman, JA; Qi, X; Rahim, M; Shen, J; Srinivas Kandadai, A; Zhang, X | 1 |
1 other study(ies) available for ether and pyrroloquinoline
| Article | Year |
|---|---|
Inhibition of the hERG potassium ion channel by different non-nucleoside human cytomegalovirus polymerase antiviral inhibitor series and the exploration of variations on a pyrroloquinoline core to reduce cardiotoxicity potential.
Topics: Antiviral Agents; Cardiotoxicity; Cytomegalovirus; ERG1 Potassium Channel; Ether; Ether-A-Go-Go Potassium Channels; Ethers; Ethyl Ethers; Humans; Nucleotidyltransferases; Potassium Channel Blockers | 2023 |